retatrutide brand name Who Makes Retatrutide? Company Behind the Weight Loss Drug RETATRUTIDE (RETA)

PMID: 34799272 3 Glutaric Aciduria Type 1 and Acute Renal Failure: Case Report and Suggested Pathomechanisms

For best results, consume immediately after exercise or as needed throughout the day to meet your protein requirements

The Phase 2/3 LIFT-AD trial (NCT04488419), evaluating once-daily subcutaneous fosgonimeton 40 mg versus placebo in 312 participants with mild-to-moderate Alzheimers disease over 26 weeks, failed its primary endpoint (Global Statistical Test composite of ADAS-Cog11 and ADCS-ADL23) and its key secondary endpoints when results were announced in September 2024

Replacing them helps restore energy, improve mental clarity and support liver health